Guardant Health is a company aimed to surmount cancer by exclusive blood tests, wide data sets, and cutting-edge analytics. Helmy Eltoukhy is the Chief Executive Officer of the company. Data supports suitable development and there is very little data available on cancer which is affecting cure development for cancer. They aim to deliver the best treatment, physicians, and patients to everyone. The establishment of data will lead to the establishment of genomic data sets which will help in studying cancer in detail. However, acquiring this data is quite a difficult task. Guardant Health is focusing to avoid biopsies which lead to risks to several patient’s health which is a hinder in early detection of cancer. Guardant Health is working on establishing data of molecular information of all stages of cancer which will require a simple blood sample for detection of cancer. Early cancer detection helps in deciding the appropriate therapeutical path for the patients. They offer job opportunities in Bioinformatics and technical development, commercial, corporate, engineering and IT, medical affairs and clinical development, and many other sectors.
